IPO4 and central nervous system cancer: Finally, the gene IPO4 with the highest risk coefficient was selected from the risk model, and its role in glioma progression was further verified by real-time quantitative PCR (RT-qPCR), Western Blot analysis and cell function experiments in glioma cell lines.